Thromboembolic and hemorrhagic complications in cancer surgery

V I Chissov; N A Osipova; P M Ermolaev; M Yu Kotin; D R El'darkhanov; T P Khovanskaya; V I Chissov; N A Osipova; P M Ermolayev; M Yu Kotin; D R Eldarkhanov; T P Khovanskaya

doi:10.17816/onco39802

Russian Journal of Oncology ›› 2011, Vol. 16 ›› Issue (1) : 26 -29. DOI: 10.17816/onco39802

Articles

other

Thromboembolic and hemorrhagic complications in cancer surgery

Author information +

History +

PDF

Abstract

Postoperative thromboembolic and hemorrhagic complications (TEC and HC) were analyzed in 300 cancer surgical patients of a different profile in the same period of time, by assessing multiple risk factors and their prognostic value. There was a preponderance of postoperative HC (5%) over TEC (3%); the patients who received anticoagulant prevention (ACP) developed HC by twice more frequently than those who did not. In different periods after surgery the patients, including ACP-receiving ones, developed TEC: deep vein thrombosis of the lower extremity on days 7-20 mainly after operations on abdominal and small pelvic organs, pulmonary artery thromboembolism on days 1-7 after thoracoabdominal operations. HO was prevalent in patients who had undergone removal of tumors of the head and neck in the complete absence of TEC. All complications were abolished without any fatal outcomes. The authors show it necessary to apply a differential approach to using ACP before extensive cancer operations (including those in patients at risk for thrombus), by taking into account the risk for high intraoperative blood loss and postoperative hemorrhage in the presence of large wound surfaces and posthemorrhagic and drug-induced hypocoagulation. It is expedient to develop an algorithm for the management of cancer surgical patients of a different profile, which provides the prevention of not only TEC, but also HC.

Keywords

thromboembolic complications / hemorrhagic complications / cancer surgery

Cite this article

Download citation ▾

V I Chissov, N A Osipova, P M Ermolaev, M Yu Kotin, D R El'darkhanov, T P Khovanskaya, V I Chissov, N A Osipova, P M Ermolayev, M Yu Kotin, D R Eldarkhanov, T P Khovanskaya. Thromboembolic and hemorrhagic complications in cancer surgery. Russian Journal of Oncology, 2011, 16(1): 26-29 DOI:10.17816/onco39802

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Бокарев И. Н. // Тромбы, кровоточивость и болезни сосудов / Под ред. И. Н. Бокарева. - М., 2008. - С. 20-23.

[2]	Вуд М. Э., Банн П. А. Секреты гематологии и онкологии. - М.; СПб., 2001. - С. 97-100; 131-140.

[3]	Державец Л. А., Прохорова В. И., Остапенко С. В., Шишло Л. М. // Тромбы, кровоточивость и болезни сосудов / Под ред. И. Н. Бокарева. - М., 2008. - С. 38-39.

[4]	Исраелян Л. А., Лубнин А. Ю., Громова В. В. и др. // Анестезиол. и реаниматол. - 2009. - № 3. - С. 24-30.

[5]	Маджуга А. В., Сомонова О. В., Елизарова А. Л. и др. // Анестезиол. и реаниматол. - 2005. - № 5. - С. 55-57.

[6]	Остеруд Б. // Тромбы, кровоточивость и болезни сосудов / Под ред. И. Н. Бокарева. - М., 2008. - С. 4-5.

[7]	Птушкин В. В. // Мед. вестн. - 2009. - № 30 (499). - С. 16-17.

[8]	Сомонова О. В., Маджуга А. В., Елизарова А. Л. и др. // Фарматека. - 2008. - № 18 (172). - С. 86-90.

[9]	Ферстае М., Фермилен Ж. Тромбозы. - М., 1986. - С. 221-225.

[10]	Шипаков В. Е., Рипп Е. Г., Цыренжапов М. Б. и др. // Анестезиол. и реаниматол. - 2009. - № 2. - С. 49-52.